Wealthspire Advisors (Maryland)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-412
| Closed | -$36K | – | 1469 |
|
|
2019
Q1 | $36K | Buy |
412
+370
| +881% | +$32.3K | ﹤0.01% | 1039 |
|
|
2018
Q4 | $3K | Sell |
42
-27
| -39% | -$1.93K | ﹤0.01% | 1965 |
|
|
2018
Q3 | $8K | Hold |
69
| – | – | ﹤0.01% | 1613 |
|
|
2018
Q2 | $7K | Buy |
69
+18
| +35% | +$1.83K | ﹤0.01% | 1669 |
|
|
2018
Q1 | $4K | Buy |
51
+3
| +6% | +$235 | ﹤0.01% | 1919 |
|
|
2017
Q4 | $4K | Buy |
48
+20
| +71% | +$1.67K | ﹤0.01% | 1911 |
|
|
2017
Q3 | $2K | Buy |
28
+5
| +22% | +$357 | ﹤0.01% | 1997 |
|
|
2017
Q2 | $1K | Buy |
23
+14
| +156% | +$609 | ﹤0.01% | 2100 |
|
|
2017
Q1 | $0 | Buy |
+9
| New | – | ﹤0.01% | 1990 |
|
|
2016
Q4 | – | Sell |
-3
| Closed | – | – | 1815 |
|
|
2016
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1788 |
|